MPM Capital

United States
cb
MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM BioImpact strives to power novel medical breakthroughs that transform patients’ lives. MPM BioImpact invests across the biotech landscape from early stage start-ups to public companies.
Founded:1996
Firm Location:United States • California • Massachusetts • San Francisco, California • Boston, Massachusetts • Cambridge, Massachusetts • Atherton
Investor Firms That Co-Invest with MPM Capital
SR OneAbingworthRA CapitalDomain AssociatesNovartis Venture FundDeerfield ManagementAtlas VentureARCH Venture PartnersVida VenturesFPV FundPfizer Venture InvestmentsNew Enterprise Associates (NEA)Westlake Village BioPartnersLongwood FundCatalio CapitalArix BioscienceCreacion VenturesSR One Capital ManagementOsage University PartnersTaiho VenturesM Ventures (Merck)Soffinova PartnersNorwest Venture PartnersRed Tree Venture CapitalVersant VenturesDigitalis VenturesPureos BioventuresPolaris Partners5am VenturesOrbiMedGV (Google Ventures)
MPM Capital Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
Photo of Christiana Bardon, Managing Partner at MPM Capital
Christiana Bardon
MPM Capital
n/a
$25.0M
($1M - $150.0M)
Investors in Cambridge (MA)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Boston / New England (Other Lists), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed)
Photo of Detlev Biniszkiewicz, Managing Director at MPM Capital
Detlev Biniszkiewicz
MPM Capital
n/a
$25.0M
($1M - $150.0M)
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists)
+9
Photo of Stephen Curtis, Managing Director at MPM Capital
Stephen Curtis
MPM Capital
n/a
$1.5M
($100K - $5.0M)
Investors in Cambridge (MA), Investors in Boston (MA)
+9
Photo of Luke Evnin, Managing Director at MPM Capital
Luke Evnin
MPM Capital
n/a
$25.0M
($1M - $150.0M)
Investors in San Francisco (CA)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+33
Photo of Todd Foley, Managing Director at MPM Capital
Todd Foley
MPM Capital
n/a
$25.0M
($1M - $150.0M)
Investors in Boston (MA), Investors in Cambridge (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed)
+4
Photo of Ansbert Gadicke, Managing Director at MPM Capital
Ansbert Gadicke
MPM Capital
n/a
$25.0M
($1M - $150.0M)
Investors in Boston (MA), Investors in Cambridge (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed)
+13
Photo of Emily Gaudiano, Associate at MPM Capital
Emily Gaudiano
MPM Capital
n/a
$25.0M
($1M - $150.0M)
Investors in United States
Photo of Brian Goodman, Partner at MPM Capital
Brian Goodman
MPM Capital
n/a
$25.0M
($1M - $150.0M)
Investors in Cambridge (MA), Investors in Boston (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
+1
Photo of Ed Hurwitz, Managing Director at MPM Capital
Ed Hurwitz
MPM Capital
n/a
$1.5M
($100K - $5.0M)
Investors in SF Bay Area (CA), Investors in Atherton
Photo of David Kolesky, Principal at MPM Capital
David Kolesky
MPM Capital
n/a
$25.0M
($1M - $150.0M)
Investors in Boston (MA), Investors in Cambridge (MA)
Investors in Material Science (Seed), Investors in Impact (Seed), Investors in Impact (Series A), Investors in BioTech (Seed), Investors in Material Science (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Impact (Seed), Investors in Material Science (Seed), Investors in BioTech (Series A), Investors in Impact (Series A), Investors in Material Science (Series A), Investors in Boston / New England (Other Lists)
+8
Photo of Alim Ladha, Senior Associate at MPM Capital
Alim Ladha
MPM Capital
n/a
$25.0M
($1M - $150.0M)
Investors in Durham (NC), Investors in Cambridge (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Boston / New England (Other Lists)
+6
Photo of Kristen Laguerre, Partner at MPM Capital
Kristen Laguerre
MPM Capital
n/a
$25.0M
($1M - $150.0M)
Investors in Boston (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in Boston / New England (Other Lists), Investors in FinTech (Series A), Investors in FinTech (Seed)
+4
Photo of Terri Lee, Associate at MPM Capital
Terri Lee
MPM Capital
n/a
$1.5M
($100K - $5.0M)
Investors in San Francisco (CA)
Photo of Geraldine Paulus, Senior Associate at MPM Capital
Geraldine Paulus
MPM Capital
n/a
$1.5M
($100K - $5.0M)
Investors in Cambridge (MA)
Investors in Chemicals (Series A), Investors in Chemicals (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Chemicals (Seed), Investors in BioTech (Series A), Investors in Chemicals (Series A), Investors in Boston / New England (Other Lists)
+4
Photo of Devin Quinlan, Senior Associate at MPM Capital
Devin Quinlan
MPM Capital
n/a
$1.5M
($100K - $5.0M)
Investors in Cambridge (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
+2
Photo of Uciane Scarlett, Principal at MPM Capital
Uciane Scarlett
MPM Capital
n/a
$1.5M
($100K - $5.0M)
Investors in Cambridge (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in Boston / New England (Other Lists), Investors in FinTech (Series A), Investors in FinTech (Seed)
+4
Photo of Patrick Baeuerle, Managing Partner at MPM Capital
Patrick Baeuerle
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)
Photo of Vinay Bhaskar, Principal at MPM Capital
Vinay Bhaskar
MPM Capital
n/a
($0 - $0)
Investors in San Francisco (CA)
Photo of Pablo Cagnoni, Managing Partner at MPM Capital
Pablo Cagnoni
MPM Capital
n/a
($0 - $0)
Investors in San Francisco (CA)
Photo of Mitchell Finer, Managing Partner at MPM Capital
Mitchell Finer
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)
Photo of Bard Geesaman, Managing Partner at MPM Capital
Bard Geesaman
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)
Photo of William Greene, Venture Partner at MPM Capital
William Greene
MPM Capital
n/a
($0 - $0)
Investors in San Francisco (CA)
Photo of Dan Hicklin, Managing Partner at MPM Capital
Dan Hicklin
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)
Photo of Sebastian Meier-Ewert, Venture Partner at MPM Capital
Sebastian Meier-Ewert
MPM Capital
n/a
($0 - $0)
Investors in Munich (Germany)
Photo of Briggs Morrison, Managing Partner at MPM Capital
Briggs Morrison
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)
Photo of Gary Patou, Managing Partner at MPM Capital
Gary Patou
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)
Photo of Tony Rosenberg, Managing Partner at MPM Capital
Tony Rosenberg
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)
Photo of Jim Scopa, Managing Partner at MPM Capital
Jim Scopa
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)
Photo of Kazumi Shiosaki, Managing Partner at MPM Capital
Kazumi Shiosaki
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)
Photo of Greg Sieczkiewicz, Managing Partner at MPM Capital
Greg Sieczkiewicz
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)
Photo of David Stack, Managing Partner at MPM Capital
David Stack
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)
Photo of Elizabeth Stoner, Managing Partner at MPM Capital
Elizabeth Stoner
MPM Capital
n/a
($0 - $0)
Investors in Cambridge (MA)